English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/216344
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


The peptidoglycan and biofilm matrix of Staphylococcus epidermidis undergo structural changes when exposed to human platelets

AuthorsLoza-Correa, María; Ayala, Juan A.; Perelman, Iris; Hubbard, Keith; Yi, Qi-Long; Taha, Mariam; Pedro, Miguel Ángel de ; Ramirez-Arcos, Sandra
Issue Date25-Jun-2019
PublisherPublic Library of Science
CitationPLoS ONE 14 (2019)
AbstractStaphylococcus epidermidis is a bacterium frequently isolated from contaminated platelet concentrates (PCs), a blood product used to treat bleeding disorders in transfusion patients. PCs offer an accidental niche for colonization of S. epidermidis by forming biofilms and thus avoiding clearance by immune factors present in this milieu. Using biochemical and microscopy techniques, we investigated the structural changes of the peptidoglycan (PG) and the biofilm matrix of S. epidermidis biofilms formed in whole-blood derived PCs compared to biofilms grown in glucose-supplemented trypticase soy broth (TSBg). Both, the PG and the biofilm matrix are primary mechanisms of defense against environmental stress. Here we show that in PCs, the S. epidermidis biofilm matrix is mainly of a proteinaceous nature with extracellular DNA, in contrast to the predominant polysaccharide nature of the biofilm matrix formed in TSBg cultures. PG profile studies demonstrated that the PG of biofilm cells remodels during PC storage displaying fewer muropeptides variants than those observed in TSBg. The PG muropeptides contain two chemical modifications (amidation and O-acetylation) previously associated with resistance to antimicrobial agents by other staphylococci. Our study highlights two key structural features of S. epidermidis that are remodeled when exposed to human platelets and could be used as targets to reduce septic transfusions events.
Publisher version (URL)http://dx.doi.org/10.1371/journal.pone.0211132
Identifiersdoi: 10.1371/journal.pone.0211132
issn: 1932-6203
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
AyalaJA_Thepeptidoglycan.pdf2,23 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.